Food and pharma demand for green packaging transforms the flexible packaging coatings market
Price concerns regarding sustainable coatings will be countered by their environmental and durability benefits, finds Frost & Sullivan.
The flexible packaging coatings market is set to witness robust growth due to the increasing need to enhance the shelf life of products in the North American food and pharmaceutical industry. Packaging coatings for the food segment holds the largest market trailed by the pharmaceutical sector. The latter trails as a result of the stringent regulations and long duration taken for product launch, making pharmaceuticals a less ventured sector. Rising consumer preference for lightweight products and the need to improve the quality of packaged contents are opening new avenues for market expansion of flexible packaging coatings.
Recent analysis from Frost & Sullivan, North American Flexible Packaging Coatings for the Food and the Pharmaceuticals Markets, finds that the market earned revenues of $1.44 billion in 2014 and estimates this to reach $1.97 billion in 2021. The study covers heat seal coatings, cold seal coatings, barrier coatings, co-extrusion primers and functional additives.
The enhanced efficiency, recyclability and composability of sustainable coatings will make green packaging a feasible option for North American market participants. Higher adaptation of sustainable coatings is observed throughout the forecast period. Thus, in place of solvent-based resins, formulators are turning to bio-based alternatives to develop flexible packaging coating solutions.
“Approximately 50 percent of the US population aged between 18 and 35 prefers to purchase products with labels that declare them to be environment friendly,” said Frost & Sullivan Visionary Science Team Leader Nandhini Rajagopal. “As this section of the population is willing to pay a premium for products with recyclable packaging.”
The price value offered by packaging coatings has encouraged cost conscious integrated packaging providers and pure players to adapt the product. Technological innovations in flexible packaging coatings such as ultra-thin coatings using nanotechnology and bio-based solutions offer significant growth opportunities. These coatings provide superior barrier protection as well as help in lowering the packaging layers, thus providing comprehensive quality and convenience.
“Evidently, novel flexible packaging coatings with an attractive price-performance ratio and innovative customer support services are key differentiators in the highly competitive and fragmented market,” summed up Rajagopal. “With the growing presence of participants with specialized product development capabilities and the need for heavy investments in R&D set-ups for innovation, tier 1 participants will enjoy considerable opportunities for mergers and acquisitions.”
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance